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Decreasing Glutamate Buffering Capacity Triggers
Oxidative Stress and Neuropil Degeneration
in the Drosophila Brain
optic lobes. Similarly, dEAAT1 was principally detected
in the neuropil in the larval brain and ventral cord (4 and
5). High expression was also observed in the larval optic
proliferative centers that give rise to the adult optic neu-
romers (panel 4, see also Figure 1B, panel 1), in agree-
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France the whole brain and ventral cord neuropil (Figure 1B,
panels 1 and 3), but not in the cortex. In contrast, native
GFP protein expressed with dEAAT1-GAL4 was de-
tected in numerous large cell bodies scattered atSummary
the periphery of the CNS corresponding to dEAAT1-
expressing cells, but not in the neuropil (2). This showsL-glutamate is both the major brain excitatory neuro-
that GFP alone does not freely diffuse into the neuropil.transmitter [1, 2] and a potent neurotoxin [3, 4] in mam-
Similarly, in adult dEAAT1-GAL4, UAS-dEAAT1-GFPmals. Glutamate excitotoxicity is partly responsible for
flies, nearly all brain neuropil regions appeared GFPcerebral traumas evoked by ischemia [5, 6] and has
positive whereas the cell bodies were not (Figure 1C,been implicated in several neurodegenerative dis-
panel 1). We noted that dEAAT1-GFP seems to accumu-eases including amyotrophic lateral sclerosis (ALS)
late in small, intensely fluorescent spots (arrows in Fig-[7–9]. In contrast, very little is known about the function
ure 1C, panels 2 and 3) that may correspond to synapticor potential toxicity of glutamate in the insect brain.
clusters. In contrast, the nonspecific membrane markerHere, we show that decreasing glutamate buffering
mCD8-GFP was addressed to both cell bodies and neu-capacity is neurotoxic in Drosophila. We found that
ropil extensions in adult dEAAT1-GAL4, UAS-mCD8-the only Drosophila high-affinity glutamate trans-
GFP flies (arrowheads in Figure 1C, panels 5 and 6) andporter, dEAAT1 [10–13], is selectively addressed to
did not accumulate in specific spots.glial extensions that project ubiquitously through the
To identify the cells expressing dEAAT1 in Drosophila,neuropil close to synaptic areas. Inactivation of
we expressed an nls-lacZ reporter that targets -gal-dEAAT1 by RNA interference led to characteristic be-
actosidase to the nucleus under the control of dEAAT1-havior deficits that were significantly rescued by ex-
GAL4 and performed colabeling experiments. In thepression of the human glutamate transporter hEAAT2
third-instar larval CNS, most dEAAT1 cells were foundor the administration in food of riluzole, an anti-excito-
to be cortical cells that coexpress the glial marker Repotoxic agent used in the clinic for human ALS patients.
(Figure 1D, panels 1 and 5) as previously shown in em-Signs of oxidative stress included hypersensitivity to
bryos [13]. dEAAT1 is also present in the midline glia,the free radical generator paraquat and rescue by the
which express neither Repo (2 and 6) nor the neuronalantioxidant melatonin. Inactivation of dEAAT1 also re-
marker Elav (not shown). In the adult CNS, dEAAT1-sulted in shortened lifespan and marked brain neuropil
expressing cells also colocalize with Repo (4 and 8)degeneration characterized by widespread microva-
except for a subset of cells with a small nucleus in thecuolization and swollen mitochondria. This suggests
optic lobe (3 and 7). Therefore, dEAAT1 appears to bethat the dEAAT1-deficient fly provides a powerful ge-
predominantly glial at all stages. Remarkably, the trans-netic model system for molecular analysis of gluta-
porter protein is excluded from the cell bodies and selec-mate-mediated neurodegeneration.
tively addressed to cytoplasmic extensions that project
into the neuropil.
Results and Discussion
dEAAT1 Is Addressed to Glial Extensions that Inactivation of dEAAT1 by RNA Interference and
Project Ubiquitously through the Neuropil Rescue by a Human Glutamate Transporter
Adult Drosophila head sections probed with a specific We inactivated dEAAT1 by heritable gene silencing with
dEAAT1 antibody revealed the quasi-ubiquitous pres- double-stranded RNA [14]. Two identical 1 kb fragments
ence of the glutamate transporter in the brain neuropil from the dEAAT1 cDNA were PCR amplified, ligated
(Figure 1A, panel 1), where synaptic contacts occur, and together in a sense-antisense orientation, and cloned
absence in the cortex, which contains neuronal and glial downstream from UAS (Figure 2A). The 1 kb fragment
cell bodies (1–3). The highest protein level was detected was complementary to the dEAAT1 cDNA from exons
in the protocerebrum bridge in the brain (2) and in the 2 to 9, a region that exhibits a low homology to dEAAT2,
the other Drosophila EAAT gene that is a selective aspar-
tate transporter [11, 12]. Two transformed lines were*Correspondence: birman@ibdm.univ-mrs.fr
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Figure 1. In Situ Localization of the Drosoph-
ila Glutamate Transporter dEAAT1
(A) In panels (1)–(3), dEAAT1 immunostaining
on frontal adult head paraffin sections.
dEAAT1 is ubiquitously detected in the adult
brain and optic lobe neuropil (np). High ex-
pression levels are detected in the lamina (la)
and in the protocerebellar bridge (pr).
dEAAT1 is not or hardly detected in cell bod-
ies of the cortex areas (cx). (4) Transverse
section of third-instar larva brain hemi-
spheres separated by the esophagus show-
ing strongly immunolabeled brain and prolif-
erative centers of the optic lobes. (5) Slant
section of third-instar larva ventral cord
showing cortical and neuropil regions.
(B) Shown in (1) is the pattern of GFP expres-
sion in the CNS of dEAAT1-GAL4, UAS-
dEAAT1-GFP larvae. The dEAAT1-GFP fusion
protein is present in the neuropil in the ventral
nerve cord and in the proliferative centers in
the optic lobes. (2) GFP alone expressed with
dEAAT1-GAL4 labels cortical cell bodies and
diffuses only slightly into the neuropil. (3)
shown is -galactosidase immunostaining of
dEAAT1-GAL4, UAS-dEAAT1-GFP, UAS-nls-
LacZ larval CNS. The nuclei of dEAAT1-
expressing cells (in red) are not surrounded
by GFP fluorescence, revealing that dEAAT1
is selectively addressed to cytoplasmic pro-
cesses from these cells that project into the
neuropil.
(C) Pictured in (1)–(3) is the adult brain of
dEAAT1-GAL4, UAS-dEAAT1-GFP flies show-
ing fluorescence in the neuropil areas and not
in cortex. dEAAT1-GFP accumulates in small
areas reminiscent of synapses (white arrow)
as shown in the protocerebellar bridge (2) or
in the brain (3). (4)–(6). mCD8-GFP expressed
with the same driver mostly stains cortical
cell bodies (white arrowheads) and does not
accumulate in specific areas of the neuropil.
(D) Double staining for -galactosidase (red
channel) and the glial-specific nuclear marker
Repo (green channel) on dEAAT1-GAL4, UAS-
nls-LacZ fly CNS. (1 and 5) Whole-mount
third-instar larva brain hemisphere. (2 and 6)
Larva ventral nerve cord. (3 and 7) Adult brain,
anterior views. (4 and 8) Adult brain, posterior
views. The colabeled glia nuclei appear in yel-
low in these multifocal confocal views. Bar:
25 m.
used in parallel as a control for possible position effects: the whole adult brain and optic lobes except for some
cells in the lamina (Figure 2C). The maintained expressionUAS-dEAAT1-IR-X and UAS-dEAAT1-IR-II, inserted re-
spectively on the first and second chromosome. in cells of the lamina indicated that the promoter fragment
included in the dEAAT1-GAL4 construct lacked regulatoryWe crossed UAS-dEAAT1-IR and dEAAT1-GAL4 flies
to induce synthesis of the double-stranded RNA selec- elements to target these cells or, alternatively, that the
RNAi mechanism did not work well in these cells. Wetively in the dEAAT1-expressing cells of the progeny.
Viable flies were recovered that developed normally and checked for selectivity of RNA interference by per-
forming RT-PCR analysis for dEAAT1, dEAAT2, anddid not have apparent behavioral defects before adult
stages. We found that when expressed with the Actin 5c in adult fly heads (Figure 2B). dEAAT1 mRNA
levels were significantly decreased in dEAAT1-GAL4,dEAAT1-GAL4 driver, the dEAAT1-IR RNA led to a com-
plete loss of endogenous dEAAT1 immunostaining in UAS-dEAAT1-IR compared to wild-type, and the resid-
Glutamate Transport Inactivation in Drosophila
601
Figure 2. In Vivo Inhibition of dEAAT1 Ex-
pression by RNA Interference
(A) Construction of the dEAAT1 RNAi trans-
gene. A fragment of dEAAT1 cDNA extending
from exon 2 to exon 9 was PCR amplified
by two different couples of primers to create
distinct restriction sites at the 5 and 3 ends.
After digestion, the two PCR products were
ligated together downstream from the UAS
activating sequence in a sense-antisense ori-
entation.
(B) RT-PCR analysis performed on adult head
RNA extracts from dEAAT1-GAL4, UAS-
dEAAT1-IR (R) compared to wild-type (WT)
flies. The dEAAT1 IR construct markedly de-
creases dEAAT1 but not dEAAT2 or Actin 5c
mRNA levels.
(C) Immunostaining of adult head sections
from wild-type (1) and dEAAT1 RNAi (2) flies
showing extinction of the dEAAT1 signal in
the brain and optic lobe except in cells of the
lamina.
(D) GFP fluorescence in whole-mount fly adult
brains from (1) dEAAT1-GAL4, UAS-dEAAT1-
GFP, (2) dEAAT1-GAL4, UAS-dEAAT1-GFP,
UAS-dEAAT1-IR, and (3) wild-type flies. In the
presence of dEAAT1-IR, the GFP fluores-
cence is decreased below the level of wild-
type tissue autofluorescence indicating that
expression of dEAAT1-GFP is dramatically
reduced. Note that the lamina cells labeled
in (C2) are not expected to be fluorescent in
(D1), as they probably do not express GAL4.
The graph presents quantification of the opti-
cal density (OD) in several brains showing that
fluorescence decrease in the presence of
dEAAT1 IR RNA is highly statistically signifi-
cant, ***p  0.0001. n is the number of brains
examined in each condition.
ual signal probably reflects the maintained expression dEAAT1-IR constructs alone immediately left the bottom
of the column and generally reached the top rapidlyin cells of the lamina. In contrast, dEAAT2 and Actin 5c
expression were unchanged. To estimate the efficiency (Figure 3A). In contrast, the dEAAT1 RNAi flies became
markedly overexcited and needed a longer delay beforeof gene silencing (Figure 2D), we coexpressed dEAAT1-
GFP alone (1) or dEAAT1-GFP with dEAAT1-IR (2) under they started climbing. About 70% remained at the bot-
tom, whirling erratically and falling down on each otherthe control of dEAAT1-GAL4 and quantified the levels
of brain fluorescence. In the presence of dEAAT1-IR for more than one minute. The RNAi flies that left the
bottom generally stopped their course many times be-RNA, GFP fluorescence was decreased below the level
of wild-type tissue autofluorescence (panel 3 and graph), fore climbing again, with only 3%–8% reaching the top
within 1 min. This phenotype was apparently not due toindicating that expression of dEAAT1-GFP was dramati-
cally reduced or abolished. Therefore, dEAAT1 ex- neuromuscular dysfunction. First, electrophysiological
recordings from the dEAAT1 RNAi fly thoracic musclespression was efficiently and selectively silenced in adult
Drosophila containing both the dEAAT1-GAL4 and UAS- demonstrated that the NMJs were still active. Second,
selective expression of the dEAAT1-IR in motor neuron-dEAAT1-IR transgenes.
The adult dEAAT1 RNAi flies exhibited striking neuro- associated peripheral glia with the gliotactin-GAL4
driver [16] did not induce similar behavioral impairmentslogical phenotypes that were already evident by casual
observation. They could walk normally, indicating that (data not shown). This indicated that the hyperexcitabil-
ity phenotype induced by dEAAT1 inactivation is mostthe glutamatergic neuromuscular junctions (NMJs) were
functional, but they flew poorly and did not try to escape likely of central origin.
Since this behavior is specific and relatively easy towhen gently touched with a finger. Although these flies
were generally hypoactive, they paradoxically over- quantify, we were able to test a number of genetic condi-
tions and pharmacological agents for their potential res-reacted when startled. This phenotype was quantified
by a startle-induced negative geotaxis test previously cuing effects on the dEAAT1 RNAi. First, it was important
to check that this phenotype is directly related to theadapted to analyze hyperexcitability behavior [15]. Flies
were placed in a column with a conic bottom end and lack of glutamate transport activity. Rescue experiments
were performed by expressing hEAAT2, a distantly re-suddenly tapped down. Wild-type Drosophila or control
flies containing either the dEAAT1-GAL4 or UAS- lated (35% amino acid identity) homolog of dEAAT1
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behavior is at least in part a consequence of glutamate
transport deficiency and likely due to an excitotoxic
accumulation of glutamate in the extracellular space.
dEAAT1 Inactivation Generates Oxidative Stress
and Decreases Life Span
The mechanisms of glutamate excitotoxicity in mammals
involve increased mitochondrial calcium concentra-
tions, resulting in oxidative stress due to the generation
of intracellular free radicals [18]. We tested the effect
of riluzole, an anti-excitotoxic agent known to inhibit
selectively glutamate release from mammalian presyn-
aptic terminals used in the clinic for ALS patients [7].
dEAAT1 RNAi flies fed with riluzole presented signifi-
cantly enhanced performance in the negative geotaxis
test as compared to the control RNAi flies (Figure 3A).
Similar results were obtained with melatonin, an antioxi-
dant and free radical scavenger [19] (Figure 3A). Oxida-
tive stress has been implicated as a cause of aging in
Drosophila [20, 21]. We found that the adult dEAAT1
RNAi flies have a significant reduction in life span: they
survive 10–13 days at 29C whereas the control dEAAT1-
GAL4, UAS-dEAAT1-IR-II, and UAS-dEAAT1-IR-X flies
survive 20, 22, and 29 days, respectively (Figure 3B).
Sensitivity to the redox-cycling agent paraquat, a free
radical generator, is a robust indicator of resistance to
oxidative stress in Drosophila [22, 23]. Exposure of 1- to
3-day-old control flies to 10 mM paraquat decreased
the survival from 90% to 50%. With the dEAAT1 RNAi
flies, survival further dropped to 14% or 28%, depending
on the UAS-dEAAT1-IR insertion line used (Figure 3C).
Collectively, these data strongly suggest that the lack
of dEAAT1 generates oxidative stress in Drosophila.
Lack of dEAAT1 Causes WidespreadFigure 3. dEAAT1 Inactivation Generates Hyperexcitability and Oxi-
Neuropil Degenerationdative Stress
The most drastic result of glutamate toxicity in mammals(A) Hyperexcitability assay of adult flies containing dEAAT1-GAL4
is neuronal degeneration and loss. We therefore carried(dT1G4) or an UAS-dEAAT1-IR insert (IR-II or IR-X) alone compared
to the dEAAT1 RNAi flies that carry both transgenes. Black boxes out an ultrastructural analysis of brain sections in RNAi
indicate the percentage of flies that climb to the top of the column and control flies. EM views of the dEAAT1 RNAi fly brains
within 1 min and white boxes the percentage of flies remaining at showed marked alterations in the whole neuropil (Figure
the bottom. Coexpression of hEAAT2, a human glutamate trans- 4A). Neurites appeared contracted compared to control,
porter, or administration of riluzole or melatonin (1 mM in the food)
and most neuronal processes contained abnormallysignificantly rescued the hyperexcitability phenotype of the dEAAT1
electron-dense cytoplasmic material (arrowheads inRNAi flies.
(B) Life span determination of flies containing one copy of dEAAT1- Figure 4A), which is characteristic of neurodegeneration.
GAL4 (dT1G4) or UAS-dEAAT1-IR (IR-X or IR-II) (white symbols) As a result, the neuropil of the RNAi flies appeared darker
compared to the dEAAT1 RNAi flies (black symbols) that contain than the control tissues in the EM images. Numerous
both transgenes. Results are expressed as the percent of living flies microvacuoles (indicated by thin arrows in Figure 4A)
as a function of time at 30C.
that are rare in the control are evident in the whole brain(C) Survival rate of control and dEAAT1 RNAi Drosophila after 48
neuropil of the dEAAT1 RNAi flies (Figure 4B). Thesehr exposure to 10 mM paraquat in 2% sucrose or to 2% sucrose
only. Independent t test results: *p  0.005, **p  0.001, ***p  microvacuoles are often surrounded by an electron-
0.0001. dense plasma membrane, suggesting that they may be
formed after the degeneration of a neuronal projection.
The mitochondria were often markedly swollen and dis-
tended, clearly revealing the internal crests (thick arrowsthat could not be inactivated by the dEAAT1-IR double-
stranded RNA. hEAAT2 (also known as GLT-1 in rat) is in Figure 4A). This was further attested by a quantitative
analysis of mitochondria diameters in the two tissuesthe major human glutamate transporter, widely ex-
pressed in brain astrocytes [17]. Whereas expression of (Figure 4C). Interestingly, swollen mitochondria were of-
ten observed in mammalian brain under conditions ofhEAAT2 alone had no effect on behavior, coexpression
of hEAAT2 with dEAAT1-IR significantly improved the cellular stress and glutamate excitotoxicity, as in trans-
genic mouse models of ALS [24, 25]. In contrast, noperformances of the RNAi flies (Figure 3A): 26% were
now able to reach the top of the column and only 38% significant effect of the lack of dEAAT1 was observed
at this resolution in the cortex area where most cellstayed at the bottom. Therefore, the hyperexcitability
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Figure 4. dEAAT1 Inactivation Causes Widespread Degeneration of the Adult Brain Neuropil
(A) Transmission electron microscopy views from head frontal sections of control (left) and dEAAT1 RNAi (right) 7-day-old adult flies at two
magnifications. The regions imaged were obtained in a neuropil area located near the central complex, but similar images could be observed
in the whole brain neuropil. Marks of degeneration in the dEAAT1 RNAi tissue include the presence of numerous microvacuoles (thin arrows),
electron-dense cytoplasmic material abundant in neurites (n) (arrowheads), and mitochondria that appear frequently swollen and distended
(thick arrows). Bar: 1 m.
(B) Density of microvacuoles in control and dEAAT1 RNAi neuropil tissues. The total number of microvacuoles counted was 409 in the dEAAT1
RNAi views and 33 in the control. Average microvacuole diameter in dEAAT1 RNAi brains was 244  0.11 nm.
(C) Mitochondria size distribution and mean diameter in control and dEAAT1 RNAi neuropil tissues. The density of mitochondria was similar
in both conditions: 6.6  0.22/100 m2 in control and 7.7  0.89/100 m2 in dEAAT1 RNAi. Independent t test results: **p  0.001, ***p 
0.0001.
bodies are located, except for the presence of myeloid- morphology were not observed. However, we found a
statistically significant loss of neurons in three dopamin-like cytoplasmic inclusions in some of the neuronal so-
mas (not shown). In particular, nuclei with an apoptotic ergic clusters when dEAAT1 expression was disrupted
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Table 1. Quantification of Dopaminergic Neurons in Control and dEAAT1 RNAi Drosophila Brains
Dopaminergic dEAAT1-GAL4
Cluster dEAAT1-GAL4 UAS-dEAAT1-IR UAS-dEAAT1-IR
PPL1 23.8  0.5 (13) 23.9  0.7 (15) 21.0  0.6 (17) (**)
PPL2 11.4  0.6 (11) 11.4  0.7 (18) 9.0  0.7 (17) (*)
PPM 29.4  0.8 (13) 30.4  0.8 (15) 26.0  0.6 (17) (**)
Results represent the number of dopaminergic neurons per cluster  SEM in different transgenic lines. The total number of brains observed
is indicated in brackets. Stastistical significance was determined with the independent t test: *p  0.05; **p  0.001.
compared to control strains (Table 1). Dopaminergic to neuronal degeneration [30]. GLT-1 knockout mice
undergo lethal spontaneous seizures, increased sus-neurons are particularly sensitive to oxidative stress
[26]. This indicates that a moderate level of neuronal ceptibility to brain injury, and much-shortened life span
[31]. These effects are evocative of the phenotypes ob-death also occurs in the absence of glutamate trans-
porter in the Drosophila brain. served in dEAAT1 RNAi flies. We do not know for the
present the mechanisms of glutamate neurotoxicity in
Drosophila. In mammals, Ca2 influx in cells overstimu-Functional Significance of Glutamate Transport
in the Drosophila Brain lated by glutamate and subsequent Ca2uptake by mito-
chondria are major factors in excitotoxicity [18, 29]. Ca2The ubiquitous and abundant expression of dEAAT1 in
the neuropil (Figure 1) suggests that glutamate plays entry can be mediated in particular by NMDA receptors.
NMDA-like receptor subunits have been identified inimportant roles in the insect CNS and that its extracellu-
lar level has to be strictly regulated, as is the case in Drosophila that are expressed in the CNS [32, 33], but
these proteins have not been functionally characterized.the mammalian brain. Accordingly, we show that inacti-
vation of dEAAT1 by RNA interference induces dramatic Glutamate transporter inactivation has also been de-
tected in sporadic and familial ALS patients [34] as wellphysiological and morphological alterations in the adult.
This was an unexpected finding, since glutamate was as in mouse models of this disease [35]. Although the
pathogenetic relevance of glutamate excitotoxicity inconsidered to date as a relatively minor neurotransmitter
in the insect brain. this disease is still a matter of debate [8, 9, 36], interfer-
Although the dEAAT1-deficient flies are rather inac- ence with glutamate-mediated toxicity is so far the only
tive, they paradoxically present a characteristic hyper- neuroprotective therapeutic strategy. The anti-excito-
excitability behavior when startled. Several lines of evi- toxic agent riluzole indeed has an effect in prolonging
dence indicate that this is at least in part due to survival in patients with ALS [37, 38]. Interestingly, we
glutamate accumulation, leading to increased oxidative observed a significant improvement in the behavior of
stress in the CNS. First, the behavior of the dEAAT1 the dEAAT1 RNAi flies when this drug was added to the
RNAi flies is significantly rescued by the expression of food. Mitochondrial swelling and changes of morphol-
the human glutamate transporter hEAAT2. Second, ad- ogy have been reported in the motor neurons of ALS
ministration of the anti-excitotoxic agent riluzole or the patients and in mouse models of the disease [24, 25].
free radical scavenger melatonin both have a significant Swollen mitochondria are also apparent in the degener-
rescuing effect. Third, the dEAAT1 RNAi flies have ating neuropil of dEAAT1 RNAi Drosophila. Therefore, the
increased sensitivity to the free radical generator para- phenotype of dEAAT1 RNAi flies exhibits striking similari-
quat, suggesting that the lack of dEAAT1 triggers oxida- ties with some of the symptoms associated with ALS.
tive stress. Similarly in mammals, mitochondrial dys- In conclusion, decreasing glutamate buffering capac-
function and intracellular free radical generation are ity in the Drosophila brain leads to various neurological
primary effects of glutamate excitotoxicity [27–29]. Fourth, defects, which suggest that extracellular glutamate ac-
these flies have a shortened lifespan and present patent cumulation is neurotoxic in insects. The dEAAT1 RNAi
signs of neurodegeneration in the CNS, including a mod- flies provide a new genetic model system to study the
est but significant loss of dopaminergic neurons. Degen- molecular mechanisms of glutamate-mediated neuro-
eration was most prominent in the neuropil, suggesting toxicity and its involvement in various neurodegenera-
that the neurites are principally affected. This result fits tive conditions.
well with our observation that the dEAAT1 transporter
is selectively addressed to the neuropil and excluded Supplemental Data
from the cell bodies that lay in the cortex. It can be Supplemental data including detailed Experimental Procedures are
noted that embryos and larvae of dEAAT1 RNAi flies available at http://www.current-biology.com/cgi/content/full/14/7/
599/DC1/.did not present any degeneration phenotype, behavior
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